Five Complimentary Webinars to Showcase Case Studies and Patient Reported Outcome Strategies
PITTSBURGH, June 9 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced its 2009 ePROficiency(TM) Web seminar series on Patient Reported Outcomes (PRO).
The webinar series is a continuation of invivodata’s educational initiative which focuses on recent regulatory and industry trends related to PROs. Each of the series’ five webinars is derived from presentations that were delivered by industry experts during invivodata’s recently concluded ePROficiency Conference in Naples, FL.
Each complimentary webinar will feature international pharmaceutical researchers delivering insight on specific aspects of PRO in clinical research and answering questions on topics including:
“We’ve always been very pleased with the response to our webinar programs, which represents the growing interest we’ve seen in PROs for clinical research,” said Dr. Jean Paty, chief scientist and regulatory advisor at invivodata’s consulting division, PRO Consulting(R). Considering the evolving use of PROs and its regulatory implications, it’s no surprise that so many global trial sponsors are eager to learn more about the latest PRO strategies and trends.”
To register for any of the webinars or to see a complete schedule of upcoming invivodata events, please visit http://www.invivodata.com/eweb/.
About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata’s solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.
CONTACT: Christine Tobin, Corporate Communications Specialist of
invivodata inc., +1-412-390-3000, ext. 3502, ctobin@invivodata.com
Web site: http://www.invivodata.com/
